Latest Breaking News On - Sean proehl - Page 1 : comparemela.com

Dermata Therapeutics Announces Exercise of Warrants for $2 66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Dermata Therapeutics Announces Exercise of Warrants for $2 66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSean proehlHc wainwright coDermata therapeutics incExchange commissionDermata therapeuticsSecurities actPrivate securities litigation reform actIhr portfolio

Dermata Therapeutics Announces Exercise of Warrants for $2 66 Million in Gross Proceeds Priced At-th

Dermata Therapeutics Announces Exercise of Warrants for $2 66 Million in Gross Proceeds Priced At-th
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSean proehlDermata therapeutics incExchange commissionHc wainwright coDermata therapeuticsSecurities actPrivate securities litigation reform act

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial enrollment remains on track Dermata continues discussions with potential botulinum toxin partners for DMT410 Received issuance of Japanese patent for DMT410 for the treatment of hyperhidrosis -SAN DIEGO, CA / ACCESSWIRE / May 15, 202.

San diegoUnited statesGerry proehlSean proehlPartnership discussionsCompany spongillaExchange commissionSpongilla treatment of acne researchDermata therapeutics incAcne researchDermata therapeuticsChief executivePrivate securities litigation reform actEnded march

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSean proehlGerry proehlExchange commissionPartnership discussionsSpongilla treatment of acne researchDermata therapeutics incCompany spongillaAcne researchDermata therapeuticsChief executivePrivate securities litigation reform actEnded marchIhr portfolio

Dermata Therapeutics : Provides Corporate Update and Reports First Quarter 2024 Financial Results - Form 8-K

Dermata Therapeutics : Provides Corporate Update and Reports First Quarter 2024 Financial Results - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoGerry proehlSean proehlExchange commissionPartnership discussionsDermata therapeutics incCompany spongillaSpongilla treatment of acne researchDermata therapeutics provides corporate updateReports first quarterAcne researchChief executivePrivate securities litigation reform actEnded march